Herbst Bruk 4
4 · Zomedica Pharmaceuticals Corp. · Filed Jan 14, 2019
Insider Transaction Report
Form 4
Herbst Bruk
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-10+300,000→ 300,000 totalExercise: $1.52From: 2019-01-10Exp: 2021-01-10→ Common Shares, without par value (300,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.